You are here

Company Monitoring Page for Shire

latest headlines for company on cafepharma

Shire Acquisition Bolsters Its Rare, And Maybe Not-So-Rare, Disease Portfolio

Seeking Alpha

Mon, 05/19/14 - 09:23 am

Tags:

Shire, M&A, liver disease, Lumena Pharmaceuticals, LUM001, LUM002, obesity

Shire to submit dry eye treatment to U.S. drug regulator

Yahoo/Reuters

Fri, 05/16/14 - 03:45 pm

Tags:

Shire, dry eye disease, Lifitegrast

Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs

Seeking Alpha

Fri, 05/16/14 - 08:20 am

Tags:

Amgen, Biocryst, GSK, Corcept Therapeutics, Merck KGaA, Ligand Pharmaceuticals, MannKind, Pfizer, Shire, Receptos, Opexa

Shire buys Lumena Pharma for at least $260 million

Yahoo/Reuters

Mon, 05/12/14 - 08:10 am

Tags:

Shire, Lumena Pharmaceuticals, M&A

Shire declines to comment on any specifics of 'M&A frenzy'

Reuters

Thu, 05/1/14 - 08:43 am

Tags:

M&A, Shire, Allergan

Shire says new dry-eye drug fails to meet trial goal

Yahoo/Reuters

Wed, 04/30/14 - 10:23 am

Tags:

Shire, dry eye disease, Lifitegrast

Shire Gains on Report Allergan Is Preparing Takeover Bid

Bloomberg

Tue, 04/29/14 - 09:57 am

Tags:

Shire, Allergan, M&A, Valeant Pharmaceuticals

Allergan made a pass at Shire before Valeant came calling

Fierce Biotech

Fri, 04/25/14 - 09:53 am

Tags:

Valeant Pharmaceuticals, M&A, Allergan, Shire

Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together

Yahoo/Bloomberg

Tue, 04/22/14 - 10:07 am

Tags:

Pfizer, AstraZeneca, M&A, Bristol-Myers Squibb, Shire, Amgen, AbbVie

Top 10 Pharma M&A deals of 2013

Fierce Pharma

Thu, 04/17/14 - 08:29 am

Novartis to Shire Said to Weigh Bids for ThromboGenics

Bloomberg

Mon, 04/14/14 - 06:49 pm

Tags:

Shire, ThromboGenics, Novartis, Roche, Valeant Pharmaceuticals, Regeneron, Allerg

New attention disorder could equal a big new ADHD drug market

Fierce Pharma

Mon, 04/14/14 - 06:27 pm

Tags:

Strattera, Sluggish Cognitive Tempo, Shire, Eli Lilly, attention deficit disorder, ADD

Deadly Bowel Infection Draws Drugmakers Seeking Cures

Bloomberg

Mon, 04/14/14 - 08:37 am

Tags:

Merck, Sanofi, Actelion, Shire, Clostridium Difficile

Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals

Yahoo/Zacks.com

Thu, 03/27/14 - 09:47 am

Tags:

Eli Lilly, Shire, Salix, AstraZeneca, Cubist Pharmaceuticals, M&A

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

Wall St 24/7

Wed, 03/19/14 - 10:24 am

Tags:

Vidara, Shire, Perrigo, M&A, Jazz Pharmaceuticals, Ireland, Endo Health Solutions, biotech, Amarin, Alkermes

Europe’s Half-Empty Pharma Market

WSJ Online

Mon, 03/17/14 - 10:55 am

Tags:

Europe, Bayer, Novo Nordisk, Shire, Merck KGaA

Shire's strong earnings outlook sends shares to new high

Reuters

Thu, 02/13/14 - 09:19 am

Tags:

earnings, Shire

Shire scraps Vyvanse for depression after failed trials

Yahoo/Reuters

Fri, 02/7/14 - 09:37 am

Tags:

Shire, Vyvanse, ADHD, clinical depression

How Sangamo BioSciences, Inc. Is Partnering to Success

Motley Fool

Fri, 01/31/14 - 08:15 am

Tags:

Sangamo BioSciences, zinc-finger proteins, Shire, Biogen Idec

This Week in Biotech: Clinical Success, Plus Wheeling and Dealing

Motley Fool

Sun, 01/26/14 - 10:46 am

Tags:

BioDelivery Sciences, Endo Health Solutions, Karyopharm Therapeutics, Repligen, Biomarin, Ariad Pharmaceuticals, Eli Lilly, GSK, Shire

Pages

last 30 twitter posts